胰腺癌相关生物活性标志物研究
摘要
肿瘤相关生物活性标志物主要是在肿瘤发生发展过程中出现的基因变化以及合成和分泌的异常蛋白质,并可以用于诊断和鉴别肿瘤的物质。临床中胰腺癌发生是一个复杂的多基因改变以及多种蛋白表达异常的结果,这可导致相应基因突变以及蛋白的高表达,同时部分指标可以成为胰腺癌相关生物活性标志物。
出处
《中华普通外科学文献(电子版)》
2009年第3期4-7,共4页
Chinese Archives of General Surgery(Electronic Edition)
参考文献5
-
1Koji Yamaguchi,Munechika Enjoji,Manabu Nakashima,Makoto Nakamuta,Takashi Watanabe,Masao Tanaka.Novel serum tumor marker, RCASl, in pancreatic diseases[J].World Journal of Gastroenterology,2005,11(33):5199-5202. 被引量:12
-
2Constantinos Giaginis,Demetrios Davides,Apostolos Zarros,Olga Noussia,Adamantia Zizi-Serbetzoglou,Gregorios Kouraklis,Stamatios Theocharis. Clinical Significance of Tumor-associated Antigen RCAS1 Expression in Human Pancreatic Ductal Adenocarcinoma[J] 2008,Digestive Diseases and Sciences(6):1728~1734
-
3Noritoshi Kobayashi,Masahiko Inamori,Koji Fujita,Toshio Fujisawa,Nobutaka Fujisawa,Hirokazu Takahashi,Masato Yoneda,Yasunobu Abe,Harunobu Kawamura,Takeshi Shimamura,Hiroyuki Kirikoshi,Kensuke Kubota,Takashi Sakaguchi,Satoru Saito,Lawrence J. Saubermann,Atsushi Nakajima. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms[J] 2008,Journal of Hepato - Biliary - Pancreatic Surgery(2):169~177
-
4Elizabeth G. Grubbs MD,Zeinab Abdel-Wahab MD, PhD,Douglas S. Tyler MD, FACS,Scott K. Pruitt MD, PhD, FACS. Utilizing Quantitative Polymerase Chain Reaction to Evaluate Prostate Stem Cell Antigen as a Tumor Marker in Pancreatic Cancer[J] 2006,Annals of Surgical Oncology(12):1645~1654
-
5Maurizio Ventrucci,Antonio Cipolla,Chiara Racchini,Riccardo Casadei,Patrizia Simoni,Lucio Gullo. Tumor M2-Pyruvate Kinase, a New Metabolic Marker for Pancreatic Cancer[J] 2004,Digestive Diseases and Sciences(7-8):1149~1155
二级参考文献17
-
1Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H,Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996; 77:1501-1509.
-
2Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nature Medicine 1999; 5:938-542.
-
3Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, AmadaS, Ogawa S, Kobayashi H, Nakashima M, Watanabe T,Nakano H. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clinical Cancer Res 1999; 5:1449-1453.
-
4Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S,Sakai K, Nakashima M, Watanabe T, Nakano H. The clinicalsignificance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.Gynecol Oncol 2000; 79:424-429.
-
5Takahashi H, Iizuka H, Nakashima M, Wada T, Asano K,Ishida-Yamamoto A, Watanabe T. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001; 26:140-144.
-
6Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T,Tsuchiya F, Ogawa S, Muramatsu M, Sasano H. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. Br J Cancer 2001; 85:1731-1737.
-
7Tsuneizumi M, Nagai H, Harada H, Kazui T, Emi M. Ahighly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer. Ann Human Biol 2002; 29:457-460.
-
8Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H,Choi I, Taguchi K, Kotoh K, Shimada M, Sugimachi K,Tsuneyoshi M, Nawata H, Watanabe T. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma.Cancer Lett 2001; 168:197-202.
-
9Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K,Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T,Kondo S, Katoh H. RCAS1 as a tumour progression marker:an independent negative prognostic factor in gallbladder cancer. Br J Cancer 2001; 85:1922-1927.
-
10Kubokawa M, Nakashima M, Yao T, Ito KI, Harada N,Nawata H, Watanabe T. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. International J Oncol 2001; 19:695-700.
共引文献11
-
1程晶娟,白明.肿瘤相关抗原RCAS1与恶性肿瘤的关系[J].肿瘤防治研究,2006,33(6):468-470. 被引量:1
-
2杨盈赤,廖泉,赵玉沛.胰腺癌血清肿瘤标志物的研究近况[J].腹部外科,2007,20(3):186-187. 被引量:3
-
3曲佳,张伟华.表达于SiSo细胞上的受体结合性癌抗原的研究进展[J].白血病.淋巴瘤,2007,16(2):152-154.
-
4杨盈赤,赵玉沛,廖泉,张太平,胡亚,戴梦华.RCAS1在胰腺癌诊断中的作用[J].中华外科杂志,2009,47(13):999-1001. 被引量:12
-
5廖泉,赵玉沛.血清肿瘤标志物在胰头部肿块鉴别诊断中的作用[J].中国实用外科杂志,2009,29(8):628-630. 被引量:3
-
6耿瑞慧,李淑德,李兆申.SiSo细胞表达的受体结合型癌抗原基因与胰腺癌[J].中华胰腺病杂志,2010,10(1):66-68.
-
7曾林山,肖卫东,李勇.胰腺癌血清肿瘤标志物的研究现状[J].国际外科学杂志,2010,37(12):839-843. 被引量:6
-
8王凯,石欣,黄毅,黄聪.肿瘤标志物对胰腺癌诊断的研究进展[J].东南大学学报(医学版),2011,30(5):793-796. 被引量:5
-
9徐春华,于力克,王清波.非小细胞肺癌患者血清RCAS1水平检测临床意义分析[J].中华肿瘤防治杂志,2013,20(5):347-349. 被引量:3
-
10赵琳.胰腺癌相关血清学肿瘤标志物的研究现状(综述)[J].中国城乡企业卫生,2013,28(6):24-27.
-
1王冬飞,王建国.胰腺癌相关的生物活性标志物和基因标志物研究进展[J].国际消化病杂志,2003,25(z1):67-69.
-
2张曙云,沈征,钱凯先.2型糖尿病大鼠基因表达变化的研究[J].科技通报,2007,23(3):368-371. 被引量:1
-
3周丽峰,缪应雷.炎症性肠病的生物学活性标志物的研究进展[J].世界华人消化杂志,2011,19(31):3229-3236. 被引量:7
-
4何艳屏,冯浩华,邱霞.胸腔积液腹水生化检查指标与临床应用[J].医学信息,2011,24(5):1228-1228. 被引量:1
-
5miRNA:肺癌新发病机制与药物靶点[J].河南医学研究,2006,15(3):256-256.
-
6唐卫中.结直肠癌发生发展的相关基因[J].广西医学,2005,27(9):1311-1313. 被引量:2
-
7HIV-1感染引起U937前单核细胞和HUT78 T细胞的大量蛋白表达异常[J].传染病网络动态,2005(11):11-11.
-
8赵咏梅,赵志炜,姬志娟,盛树力.APP17肽对D半乳糖脑老化模型小鼠神经元凋亡的影响[J].中华老年医学杂志,2002,21(3):202-205. 被引量:9
-
9吴小平,莫雅娴.炎症性肠病非侵入性标志物研究进展[J].国际消化病杂志,2009,29(1):61-64. 被引量:12
-
10彭定琼,郭晓蕙,陈宇,高妍.胰岛素受体底物2在2型糖尿病大鼠肌肉、脂肪、肝脏中的蛋白表达及其意义[J].中国预防医学杂志,2006,7(5):405-407. 被引量:9